Tom Rawlings »

Revance Therapeutics shares owned by Tom Rawlings

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Tom Rawlings from 13F filings

Historical chart of Tom Rawlings investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Tom Rawlings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Tom Rawlings

Quarter filed Position value Share count Share price at filing
2022-12-31 $6.8M 370k 18.46
2022-09-30 $5.8M 215k 27.00
2022-06-30 $3.0M 217k 13.82
2022-03-31 $4.3M 222k 19.50
2021-12-31 $4.7M 289k 16.32
2021-09-30 $8.5M 304k 27.86
2021-06-30 $10M 345k 29.64
2021-03-31 $11M 384k 27.95
2020-12-31 $12M 430k 28.34
2020-09-30 $11M 438k 25.14
2020-06-30 $12M 484k 24.42
2020-03-31 $7.1M 480k 14.80
2019-12-31 $9.1M 560k 16.23
2019-09-30 $456k 35k 13.01
2019-06-30 $356k 27k 12.98
2019-03-31 $437k 28k 15.77
2018-12-31 $995k 49k 20.12
2018-09-30 $1.2M 49k 24.85
2018-06-30 $1.1M 42k 27.46
2018-03-31 $1.4M 45k 30.80
2017-12-31 $1.8M 49k 35.76
2017-09-30 $1.5M 53k 27.54
2017-06-30 $1.4M 54k 26.40
2017-03-31 $1.2M 57k 20.79
2016-12-31 $1.3M 61k 20.70
2016-09-30 $175k 11k 16.19
2016-06-30 $143k 11k 13.57